Measure Labs, Inc. (Dba Preemptiveai, Inc.)

Measure Labs, Inc. (Dba Preemptiveai, Inc.) has 1 AI-enabled medical device on the FDA list. The first decision was on February 13, 2026 and the most recent on February 13, 2026 (PreemptiveAI Clinical SDK). Its most common review panel is Cardiovascular (1 device).